1. Home
  2. PSTG vs INSM Comparison

PSTG vs INSM Comparison

Compare PSTG & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTG
  • INSM
  • Stock Information
  • Founded
  • PSTG 2009
  • INSM 1988
  • Country
  • PSTG United States
  • INSM United States
  • Employees
  • PSTG N/A
  • INSM N/A
  • Industry
  • PSTG Electronic Components
  • INSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • PSTG Technology
  • INSM Health Care
  • Exchange
  • PSTG Nasdaq
  • INSM Nasdaq
  • Market Cap
  • PSTG 25.4B
  • INSM 29.0B
  • IPO Year
  • PSTG 2015
  • INSM 2000
  • Fundamental
  • Price
  • PSTG $93.78
  • INSM $166.17
  • Analyst Decision
  • PSTG Buy
  • INSM Strong Buy
  • Analyst Count
  • PSTG 18
  • INSM 19
  • Target Price
  • PSTG $79.28
  • INSM $155.88
  • AVG Volume (30 Days)
  • PSTG 2.8M
  • INSM 2.1M
  • Earning Date
  • PSTG 12-02-2025
  • INSM 10-30-2025
  • Dividend Yield
  • PSTG N/A
  • INSM N/A
  • EPS Growth
  • PSTG 4.75
  • INSM N/A
  • EPS
  • PSTG 0.41
  • INSM N/A
  • Revenue
  • PSTG $3,350,401,000.00
  • INSM $398,105,000.00
  • Revenue This Year
  • PSTG $16.25
  • INSM $32.44
  • Revenue Next Year
  • PSTG $14.66
  • INSM $123.99
  • P/E Ratio
  • PSTG $226.83
  • INSM N/A
  • Revenue Growth
  • PSTG 11.31
  • INSM 21.15
  • 52 Week Low
  • PSTG $34.51
  • INSM $60.40
  • 52 Week High
  • PSTG $94.94
  • INSM $166.44
  • Technical
  • Relative Strength Index (RSI)
  • PSTG 66.99
  • INSM 74.54
  • Support Level
  • PSTG $89.73
  • INSM $161.34
  • Resistance Level
  • PSTG $94.94
  • INSM $165.76
  • Average True Range (ATR)
  • PSTG 3.35
  • INSM 4.20
  • MACD
  • PSTG -0.13
  • INSM 0.08
  • Stochastic Oscillator
  • PSTG 93.63
  • INSM 92.20

About PSTG Pure Storage Inc.

Pure Storage Inc is a U.S.-based company that provides an enterprise data storage platform that transforms business through a dramatic increase in performance and reduction in complexity and costs. It generates revenue from two sources: product revenue, which includes the sale of integrated storage hardware and embedded operating system software; and subscription services revenue, which includes Evergreen Storage subscriptions, a unified subscription that includes Pure as-a-Service, Cloud Block Store, and Portworx. Subscription services revenue also includes professional services offerings such as installation and implementation consulting services.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

Share on Social Networks: